Oruka Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 26, 2026, 8 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedOruka Therapeutics Reports Positive Week 16 EVERLAST-B Results for ORKA-001: 61% PASI 100 at 600 mg vs. 0% Placebo
4Oct. 20, 2026, 8:42 p.m. ETView on SEC.gov
4Oct. 15, 2026, 6:15 p.m. ETView on SEC.gov
4Oct. 13, 2026, 4:34 p.m. ETView on SEC.gov
4Oct. 2, 2026, 7:54 p.m. ETView on SEC.gov
4Sept. 21, 2026, 5:38 p.m. ETView on SEC.gov
4Sept. 21, 2026, 4:57 p.m. ETView on SEC.gov
4Sept. 15, 2026, 7:18 p.m. ETView on SEC.gov
4Sept. 15, 2026, 7:17 p.m. ETView on SEC.gov
4Sept. 15, 2026, 7:15 p.m. ETView on SEC.gov
4Sept. 15, 2026, 7:14 p.m. ETView on SEC.gov
4Sept. 15, 2026, 7:11 p.m. ETView on SEC.gov
4Sept. 1, 2026, 6:36 p.m. ETView on SEC.gov
4Sept. 1, 2026, 6:35 p.m. ETView on SEC.gov
424B5Aug. 28, 2026, 4:10 p.m. ETView on SEC.gov
4Aug. 25, 2026, 4:25 p.m. ETView on SEC.gov
8-KAug. 24, 2026, 4:06 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
4Aug. 17, 2026, 6:09 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 14, 2026, 8:04 a.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 4:53 p.m. ETView on SEC.gov
4Aug. 14, 2026, 5:52 p.m. ETView on SEC.gov
4Aug. 14, 2026, 5:42 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 4:10 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 12, 2026, 5:40 p.m. ETView on SEC.gov
10-QAug. 10, 2026, 4:06 p.m. ETView on SEC.gov
8-KAug. 10, 2026, 7 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits